Poly Medicure has served the healthcare community for more than 23 years and established itself as one of the leading medical devices company in India. We are governed by our passion to serve the community by providing best healthcare devices. Our core values are defined by learning, integrity, inclusivity, care, and ownership. Polymed started its operations in 1997 and since then, there has been no stopping us.
Since the very beginning, our aim has consistently been to provide innovative and top-notch quality products, yet affordable to the patients and healthcare providers. These are manufactured with utmost care and safety at our nine manufacturing plants spread across four countries. Some of our laurels include Medical Device Company of the Year 2018 by the Department of Pharmaceuticals Ministry of Chemicals & Fertilizers – Government of India, one of the top 25 Innovative Companies by CII in 2019 and getting featured in the prestigious Forbes magazine’s Asia’s 200 best under a billion list of 2020.
Currently, our product offerings are in the areas of vascular access, dialysis and renal care, diagnostic, transfusion system, and oncology. Each of our vertical continues to grow and launch new products focusing on the clinical aspect and taking deep dive to address the pain points of both healthcare professionals & patients.
As the COVID-19 pandemic disrupts nearly every aspect of life, Polymed has turned to digital technology and analytics to help us prepare for new ways of empowering the team and serving customers once we reach the other side. We started our operations only after a few days of the nationwide lockdown to ensure that the healthcare providers get full support during these hard times. Owing to our proactive approach, we also launched ventilator adaptor and accessories, Polymask (N95 Mask), VTM, and VLTM kit, which were some of the most crucial agents, needed to fight this pandemic. Also, digital transformation was at the forefront of our plans, to ensure the safety of our employees and knowledge sharing for healthcare professionals. This situation also gave us an opportunity to engage digitally with the healthcare community by means of webinars. These virtual programs enabled us to build online learning events aimed at imparting knowledge and skills to different set of healthcare professionals. We continue to invest in our technology architecture to expedite our digital transformation and put ourselves in a stronger position coming out of the pandemic. I can proudly say that Polymed has actively and successfully contributed toward India’s fight against COVID-19.
We have achieved a unique position for ourselves as an Indian manufacturer to have a comprehensive range of products that are efficiently backed by a patient-centric approach. We plan to keep investing to strengthen our R&D to bring innovation in our offerings. Our priority now is to collaborate and work closely with all stakeholders such as the government, private sector as well as the medical research fraternity. To make the most of the opportunities, we are focusing on the growth prospects in the fast-growing segments. To achieve this, we will ensure that user-centered design should begin early and continue throughout device development.
The company continues to focus on its vision to serve people through innovative healthcare solutions and make medical devices more affordable for the global community.